Second Generation Tiancimycin-Based Antibody–Drug Conjugates Enabled by Highly Efficient Semi-synthetic Approach Specifically Targeting B-Cell Malignancies

Alexander Kiefer(German Center for Infection Research), Ben Shen(Brunel University of London), Pankajavalli Thirugnanasambantham(The Ohio State University), Christoph Rader(Scripps Research Institute), Dong Yang(Wuhan University), Natarajan Muthusamy(The Ohio State University), Dobeen Hwang(Scripps (United States)), Rakeb Tafesse(The Ohio State University), Yuan Jin(Scripps (United States)), Jing Chang(Scripps (United States)), Yanlong Jiang(Rice University), Andrew D. Steele(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology), Ajeeth Adhikari(Scripps Institution of Oceanography)
JACS Au
July 1, 2025
Cited by 2


Related Papers